Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
With Merck KGaA’s former electronics business lead Kai Beckmann now at the helm of the entire conglomerate, the new CEO is making his mark with a major outlay to support the company’s life sciences | With Merck KGaA’s former electronics business lead Kai Beckmann now at the helm of the entire conglomerate, the new CEO is making his mark with a major outlay to support the company’s life sciences arm.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Merck KGaA Swoops In With $11.3 Billion Medtech Buyout

Germany's Merck to buy Bio-Techne for $11.3 billion

Pharmabranche: Merck kauft US-Laborausrüster für zehn Milliarden Euro

Pharma: Merck stärkt Life-Science-Sparte mit US-Milliardenzukauf

Übernahme: Merck kauft US-Laborausrüster für 9,9 Milliarden

Merck: Übernahme von Bio-Techne für fast 10 Milliarden Euro

Bio-Techne Stock Soars as Germany’s Merck to Buy Biotech Company for $11.3 Billion

Bio-Techne: Merck kauft Bio-Techne für 11,3 Milliarden Dollar

Merck kauft US-Laborausrüster für zehn Milliarden - WELT

Merck: Dieser Pharmakonzern baut die Werkzeuge für die nächste Revolution

The deal expands its portfolio of life sciences tools.

Merck KGaA has agreed to acquire biotech firm Bio-Techne for $11.3 billion, the German science and healthcare firm said in…

Merck & Co. and Kelun-Biotech's sac-TMT is on fire this week with details or first reports of three positive phase 3 trials. |…

Der Pharma- und Technologiekonzern stemmt unter seinem neuen Chef Kai Beckmann die nächste Übernahme. Der Milliardendeal soll…

Merck übernimmt den US-Laborausrüster Bio-Techne für 9,9 Milliarden – ein Zukauf, auf den Investoren und Analysten seit Jahren…

Germany’s new healthcare reform initiative has already led two global drugmakers to slice their planned investments in the…